Paśnik Jarosław, Cywińska-Bernas Agnieszka, Moll Jadwiga, Moll Jacek, Sysa Andrzej, Zeman Krzysztof
Klinika Pediatrii i Immunologii Wieku Rozwojowego Uniwersytetu Medycznego w Łodzi.
Przegl Lek. 2009;66(7):359-64.
Cardiac surgery with cardiopulmonary bypass (CPB) in children with congenital heart disease induces neutrophil activation, degranulation and systemic inflammatory response. Matrix metalloproteinase-9 (MMP-9) and matrix metalloproteinase-2 (MMP-2) are enzymes involved in degranulation and leukocyte extravasation. These are secreted as a pro-enzyme in response to several inflammatory mediators and are inhibited by tissue inhibitor of metalloproteinase-1 (TIMP-1) and tissue inhibitor of metalloproteinase-2 (TIMP-2). To explore metalloproteinase activation during cardiac surgery we investigated MMP-9, MMP-2, TIMP-1 and TIPM-2 levels in young children during and after surgery. We measured the dynamics of these enzyme concentrations in peripheral blood. Additionally we measured CD11b and CD66b molecule expression on neutrophils. These investigations were carried out in 39 children, aged 5-38 months who were undergoing cardiacsurgery with cardiopulmonary bypass (CPB). Serum concentrations of MMPs and their inhibitors, CD11b and CD66b expression on neutrophils were sequentially measured before induction of anesthesia, at the initiation of CPB, after 30 minutes of CPB, at the end of CPB, 4 and 48 hours after CPB. MMP-9 concentration increased at the end of CPB and remained elevated for a period of 48 hours. The concentration of MMP-9 detected at the end of CPB positively correlated with time of CPB (r=0.68, p=0.0045). TIMP-1 concentration decreased significantly after 30 minutes of CPB, remained lowered to the end of CPB, and returned to the start of CPB level after 48 hours. CD11b and CD66b expression on neutrophils increased at the initiation of CPB. Our data confirm that MMPs play an important role in inflammatory complications after cardiac surgery in children. These findings suggest that kinetics of MMPs concentrations in serum after cardiac surgery appear to depend on many factors. We demonstrated the link between CPB duration and the MMP-9 concentration. Future studies will determine whether inhibition of MMPs activity diminishes morbidity in children after cardiac surgery.
先天性心脏病患儿体外循环心脏手术可诱导中性粒细胞活化、脱颗粒及全身炎症反应。基质金属蛋白酶-9(MMP-9)和基质金属蛋白酶-2(MMP-2)是参与脱颗粒和白细胞外渗的酶。它们作为一种前体酶,在多种炎症介质作用下分泌,并受到金属蛋白酶组织抑制剂-1(TIMP-1)和金属蛋白酶组织抑制剂-2(TIMP-2)的抑制。为探究心脏手术期间金属蛋白酶的激活情况,我们对幼儿手术期间及术后的MMP-9、MMP-2、TIMP-1和TIMP-2水平进行了研究。我们测量了外周血中这些酶浓度的动态变化。此外,我们还测量了中性粒细胞上CD11b和CD66b分子的表达。这些研究在39名年龄5至38个月、正在接受体外循环心脏手术的儿童中进行。在麻醉诱导前、体外循环开始时、体外循环30分钟后、体外循环结束时、体外循环后4小时和48小时,依次测量血清中基质金属蛋白酶及其抑制剂的浓度、中性粒细胞上CD11b和CD66b的表达。MMP-9浓度在体外循环结束时升高,并在48小时内持续升高。体外循环结束时检测到的MMP-9浓度与体外循环时间呈正相关(r = 0.68,p = =0.0045)。TIMP-1浓度在体外循环30分钟后显著下降,直至体外循环结束时仍保持较低水平,并在48小时后恢复到体外循环开始时的水平。中性粒细胞上CD11b和CD66b的表达在体外循环开始时增加。我们的数据证实,基质金属蛋白酶在儿童心脏手术后的炎症并发症中起重要作用。这些发现表明,心脏手术后血清中基质金属蛋白酶浓度的动力学似乎取决于许多因素。我们证明了体外循环持续时间与MMP-9浓度之间的联系。未来的研究将确定抑制基质金属蛋白酶活性是否能降低儿童心脏手术后的发病率。